Get started
Author

Gordana Dancer

Observed name: G. Dancer
Observed institution: Gedeon Richter (Hungary)
ORCID: 0009-0005-0666-4937
Observed ORCID: 0009-0005-0666-4937
OpenAlex ID: A5123968056
Abs0335 Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity Evaluation of the Proposed Tocilizumab Biosimilar Rgb-19 Subcutaneously Administered to Healthy Male Participants: a Phase 1, Randomised, Single-dose Cross-over Study
2025 · P. Emery, E. Choy, et al. · Annals of the Rheumatic Diseases · 2
Corrigendum to ‘Comparison of the PK, PD, safety, tolerability, and immunogenicity of proposed biosimilar RGB-19 and tocilizumab in healthy Japanese males: a phase 1, randomised, crossover study’ [EULAR Rheumatology Open 1 (2025) 282–290]
2026 · Tomoko Hasunuma, Paul Emery, et al. · EULAR Rheumatology Open
Efficacy, safety, and immunogenicity of proposed biosimilar RGB-19 and tocilizumab intravenously administered to adults with active rheumatoid arthritis and an inadequate response to methotrexate: a phase 3, randomised study
2026 · Hiroaki Matsuno, Ernest Choy, et al. · EULAR Rheumatology Open
PDF
Clinical development programme of RGB-19 as a biosimilar to tocilizumab
2026 · Ernest Choy, Gordana Dancer, et al. · Video Journal of Biomedicine
PDF
Pos0659 Efficacy, Safety and Immunogenicity of the Proposed Tocilizumab Biosimilar Rgb-19, Intravenously Administered to Participants With Active Rheumatoid Arthritis: Week 24 Data From a Phase 3 Study
2025 · E. Choy, P. Emery, et al. · Annals of the Rheumatic Diseases
Works count: 6
Citation count: 3
H-index: 1
I10-index:
Year
Topic
Type